TRPC1 and cyclic hematopoiesis: In vivo TRPC1-siRNA delivery also counteracts the increase in inflammatory biomarkers (TNF-α and MMP-9) in the lung and apoptotic biomarkers in the RV myocardium that was observed in a murine model of CH-induced PAH.